CoImmune, Inc. Appoints Michael Fekete and Greg Tibbitts to its Board of Directors
DURHAM, N.C., July 06, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company
POSTS IN CATEGORY
DURHAM, N.C., July 06, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company
58 Clinical Trial Sites, 11 Countries EDMONTON, Alberta, July 06, 2021 (GLOBE NEWSWIRE) — Translational
TORONTO, July 06, 2021 (GLOBE NEWSWIRE) — Sophi.io, The Globe and Mail’s artificial intelligence-based automation, optimization
Multi-year Agreement for Mobile Automatic Number Plate Recognition (ANPR) Solutions Support Road Safety and More
London, July 5, 2021 Ahead of the previously announced spin-off of its On-Highway business and
BOSTON and DURHAM, N.C., July 02, 2021 (GLOBE NEWSWIRE) — Parexel, a leading global clinical
Mont-Saint-Guibert, Belgium – July 2, 2021, 2:40pm CET / 8:40am ET – Nyxoah SA (Euronext
Philogen Announces R&D Program Update Fibromun shows activity in pretreated glioma and sarcoma patients; OncoFAP
SHANGHAI, China, July 02, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a
Copyright 2024 © bruneitribune.com All rights Reserved.